|
|
||||||||
1Department of Human Health and Nutritional Sciences, University of Guelph, Guelph, Ontario, Canada; and 2Medical University of Bialystok, Bialystok, Poland
Submitted 12 December 2006 ; accepted in final form 14 March 2007
Derangements in skeletal muscle fatty acid (FA) metabolism associated with insulin resistance in obesity appear to involve decreased FA oxidation and increased accumulation of lipids such as ceramides and diacylglycerol (DAG). We investigated potential lipid-related mechanisms of metformin (Met) and/or exercise for blunting the progression of hyperglycemia/hyperinsulinemia and skeletal muscle insulin resistance in female Zucker diabetic fatty rats (ZDF), a high-fat (HF) diet-induced model of diabetes. Lean and ZDF rats consumed control or HF diet (48 kcal %fat) alone or with Met (500 mg/kg), with treadmill exercise, or with both exercise and Met interventions for 8 wk. HF-fed ZDF rats developed hyperglycemia (mean: 24.4 ± 2.1 mM), impairments in muscle insulin-stimulated glucose transport, increases in the FA transporter FAT/CD36, and increases in total ceramide and DAG content. The development of hyperglycemia was significantly attenuated with all interventions, as was skeletal muscle FAT/CD36 abundance and ceramide and DAG content. Interestingly, improvements in insulin-stimulated glucose transport and increased GLUT4 transporter expression in isolated muscle were seen only in conditions that included exercise training. Reduced FA oxidation and increased triacylglycerol synthesis in isolated muscle were observed with all ZDF rats compared with lean rats (P < 0.01) and were unaltered by therapeutic intervention. However, exercise did induce modest increases in peroxisome proliferator-activated receptor-
coactivator-1
, citrate synthase, and
-hydroxyacyl-CoA dehydrogenase activity. Thus reduction of skeletal muscle FAT/CD36 and content of ceramide and DAG may be important mechanisms by which exercise training blunts the progression of diet-induced insulin resistance in skeletal muscle.
Zucker diabetic fatty rat; lipid metabolism; glucose transport; diacylglycerol; ceramide; adenosine 5'-monophosphate-activated protein kinase
This article has been cited by other articles:
![]() |
E. Diamanti-Kandarakis, C. D Christakou, E. Kandaraki, and F. N Economou Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome Eur. J. Endocrinol., February 1, 2010; 162(2): 193 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. C. Glatz, J. J. F. P. Luiken, and A. Bonen Membrane Fatty Acid Transporters as Regulators of Lipid Metabolism: Implications for Metabolic Disease Physiol Rev, January 1, 2010; 90(1): 367 - 417. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bonen, G. P. Holloway, N. N. Tandon, X.-X. Han, J. McFarlan, J. F. C. Glatz, and J. J. F. P. Luiken Cardiac and skeletal muscle fatty acid transport and transporters and triacylglycerol and fatty acid oxidation in lean and Zucker diabetic fatty rats Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2009; 297(4): R1202 - R1212. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B Haugaard, H. Mu, A. Vaag, and S. Madsbad Intramyocellular triglyceride content in man, influence of sex, obesity and glycaemic control Eur. J. Endocrinol., July 1, 2009; 161(1): 57 - 64. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Nickerson, H. Alkhateeb, C. R. Benton, J. Lally, J. Nickerson, X.-X. Han, M. H. Wilson, S. S. Jain, L. A. Snook, J. F. C. Glatz, et al. Greater Transport Efficiencies of the Membrane Fatty Acid Transporters FAT/CD36 and FATP4 Compared with FABPpm and FATP1 and Differential Effects on Fatty Acid Esterification and Oxidation in Rat Skeletal Muscle J. Biol. Chem., June 12, 2009; 284(24): 16522 - 16530. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bonen, X.-X. Han, N. N. Tandon, J. F. C. Glatz, J. Lally, L. A. Snook, and J. J. F. P. Luiken FAT/CD36 expression is not ablated in spontaneously hypertensive rats J. Lipid Res., April 1, 2009; 50(4): 740 - 748. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Junkin, D. J. Dyck, K. L. Mullen, A. Chabowski, and A. B. Thrush Resistin acutely impairs insulin-stimulated glucose transport in rodent muscle in the presence, but not absence, of palmitate Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2009; 296(4): R944 - R951. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Mullen, J. Pritchard, I. Ritchie, L. A. Snook, A. Chabowski, A. Bonen, D. Wright, and D. J. Dyck Adiponectin resistance precedes the accumulation of skeletal muscle lipids and insulin resistance in high-fat-fed rats Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2009; 296(2): R243 - R251. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Fujii, R. C. Ho, Y. Manabe, N. Jessen, T. Toyoda, W. L. Holland, S. A. Summers, M. F. Hirshman, and L. J. Goodyear Ablation of AMP-Activated Protein Kinase {alpha}2 Activity Exacerbates Insulin Resistance Induced by High-Fat Feeding of Mice Diabetes, November 1, 2008; 57(11): 2958 - 2966. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Pandke, K. L. Mullen, L. A. Snook, A. Bonen, and D. J. Dyck Decreasing intramuscular phosphagen content simultaneously increases plasma membrane FAT/CD36 and GLUT4 transporter abundance Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2008; 295(3): R806 - R813. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Moro, S. Bajpeyi, and S. R. Smith Determinants of intramyocellular triglyceride turnover: implications for insulin sensitivity Am J Physiol Endocrinol Metab, February 1, 2008; 294(2): E203 - E213. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |